In countries that bear the heaviest burden of malaria, most patients seek medicine for the disease in the private sector. Because the availability and affordability of recommended malaria drugs provided by the private-sector distribution channel is poor, donors (e.g., the Global Fund) are devoting substantial resources to fund subsidies that encourage the channel to improve access to these drugs.
Introduction
Malaria is estimated to have caused 660,000 deaths in 2010. The great majority of malaria cases and deaths are in sub-Saharan Africa, where the Democratic Republic of Congo and Nigeria alone account for more than 40% of all deaths (World Health Organization 2012) . In malaria-endemic countries, in part because public health clinics lack deep geographic reach especially into rural areas, the majority of people purchase malaria drugs from private-sector outlets such as drug shops (Laxminarayan et al. 2010 , O'Connell et al. 2011 . The private-sector accounts for 74% of malaria drug volume in the Democratic Republic of Congo and 98% in Nigeria (O'Connell et al. 2011) . Unfortunately, the private-sector supply chain fails in providing high levels of availability for the drugs recommended to treat malaria, Artemisinin Combination Therapies (ACTs). ACTs are the recommended first-line treatment for malaria, because they are significantly more effective than previous generations of drugs to which the malaria parasite has developed resistance, and because ACTs themselves are much less prone to encouraging the development of drug-resistant strains of malaria. In a study of availability of ACTs in sub-Saharan Africa, O'Connell et al. (2011) report that of private-sector outlets stocking malaria drugs, fewer than 25% had first-line quality-assured ACTs in stock. Further, the privatesector outlets priced ACTs 5-24 times higher than the previous-generation, inferior malaria drugs.
The lack of access to ACTs, and in particular the lack of access to ACTs at prices that are affordable to the poor, has motivated donors-bilateral donors such as the U.S. Government, multilateral agencies such as the World Bank and the Global Fund to Fight AIDS, Tuberculosis and Malaria, large non-governmental organizations such as the Clinton Health Access Initiative, and private philanthropic organizations such as the Bill and Melinda Gates Foundation-to intervene to improve access. Because of the important role played by the private-sector distribution channel, a primary way donors seek to achieve this objective is by designing and then funding product subsidies that encourage the channel to make decisions (e.g., stocking and pricing decisions) that improve the availability and affordability of the product to end consumers. Donors have committed a budget of $216 million for ACT subsidies through the Affordable Medicines Facility-malaria (Adeyi and Atun 2010) . Bitran and Martorell (2009) emphasize that a fundamental issue that makes designing subsidies for ACTs different from designing subsidies for other products (e.g., non-health goods or preventative-health goods) is that demand for ACTs is uncertain in that it "arises from an unpredictable event," namely infection, which triggers the need for treatment. The uncertainty in the number of infections is most pronounced at a narrow geographic level (e.g., the area served by a retail outlet). Alemu et al. (2012) report that the total number of malaria cases in a small geography (i.e., the area served by a single health clinic) varies significantly from year to year with no secular trend. Gomez-Elipe et al. (2007) report a similar finding at the geographic level of a province. A number of factors contribute to the variability in the number of malaria cases: weather (rainfall, temperature) which impacts the population of the anopheles mosquitoes carrying the malaria parasite, the extent of parasite resistance to commonly-used malaria drugs, the health conditions in the human population which impact susceptibility to the malaria parasite, and the extent of malaria control and prevention activities such as the spraying of insecticide (Gomez-Elipe et al. 2007 , Alemu et al. 2012 . The fact that each of these factors evolves in ways that can be challenging to predict contributes to uncertainty in the demand for malaria drugs.
A key question for donors in designing a subsidy is how it should be administered in the supply chain. One option is to reduce a firm's cost of acquiring each unit via a purchase subsidy. A second option is to increase the revenue for each unit the firm sells via a sales subsidy. Voucher schemes have been used to implement sales subsidies at the retail level. The voucher provides a means by which the subsidy provider can verify a retailer's sales to end consumers. A consumer presents a voucher when purchasing the product and receives a discount. For each redeemed voucher the retailer submits, the retailer receives a subsidy payment. In its report advising the global public health donor community on the design of subsidies for ACTs, the Institute of Medicine of the National Academies explicitly considers these two types of subsidies (Arrow et al. 2004 ).
The donor's purpose in improving the availability and affordability of ACTs is ultimately to increase the consumption of ACTs by those afflicted by malaria. We formulate the donor's problem as one of designing a purchase subsidy and sales subsidy to maximize consumer purchases subject to a constraint on the donor's budget. Because donors are primarily interested in the availability and affordability of ACTs at the point where products are made available to consumers (Laxminarayan and Gelband 2009) , we focus on the stocking and pricing decisions at the retail level. Our main finding is that the optimal subsidy consists solely of a purchase subsidy, i.e., the optimal sales subsidy is zero. This result, which we establish in the context of homogenous retailers, extends when the retailers are heterogenous. The result holds when the product life cycle is long relative to the replenishment interval, as is typically the case for ACTs. The result breaks when the product life cycle is short. Then, it is optimal to offer a sales subsidy (in addition to a purchase subsidy) if and only if customer heterogeneity and the donor's budget are sufficiently large.
Several papers in the economics literature starting with Pigou (1932) have examined the design of subsidies to encourage consumption of products with positive externalities. In this stream of literature, the donor's utility depends on the recipient's consumption of the product (e.g., BenZion and Spiegel 1983). Daly and Giertz (1972) argue that if the donor's utility depends on the recipient's consumption choices, then the donor prefers a product subsidy to a cash transfer. In a product diffusion model, Kalish and Lilien (1983) examine how a donor should vary her product subsidy over time to accelerate consumer adoption. In a field study, Dupas (2010) finds that shortterm subsidies positively impact long-term adoption of ITNs. Our work differs from these papers in that they focus on the impact of subsidies on consumption levels, assuming product availability, whereas we focus on the impact of subsidies on product availability (and pricing), which in turn impacts consumption.
In an epidemiological model of malaria transmission, immunity, and drug resistance, Laxminarayan et al. (2006 Laxminarayan et al. ( , 2010 study the impact of reductions in the retail price of ACTs on consumption. From simulation results under plausible parameters, they conclude that donor-funded price reductions are welfare enhancing. To capture the richness of disease progression and resistance, Laxminarayan et al. (2006 Laxminarayan et al. ( , 2010 abstract away from the details of the distribution channel. We complement their macro-level approach with a micro-level approach that focuses on capturing these details: demand uncertainty, supply-demand mismatch, and the impact of subsidies on stocking and pricing decisions in the distribution channel.
Our micro-level approach is part of a stream of work in operations management and marketing that looks at the impact of incentives on the behavior of firms in a supply chain. Taylor (2002) , Drèze and Bell (2003) , Krishnan et al. (2004) and Aydin and Porteus (2009) examine a manufacturer who sets a per-unit purchase price and a rebate-a payment the manufacturer makes to the retailer for each unit the retailer sells to end consumers. From the retailer's perspective, a rebate is similar to a sales subsidy in that both reward the retailer for sales, and a reduction in the purchase price is similar to a purchase subsidy in that both reward the retailer for purchasing. Taylor (2002), Drèze and Bell (2003) , Krishnan et al. (2004) and Aydin and Porteus (2009) find that a manufacturer benefits by rewarding the retailer based on her sales. Drèze and Bell (2003) offer a sharper result: a manufacturer is better off rewarding the retailer based on her sales than her purchases. In contrast, we show that it is optimal for a donor to reward the retailer not for sales, but only for purchases. Two factors contribute to this divergence in results. First, the objectives of the incentive-designers differ: the donor's objective is to maximize consumer purchases, whereas the manufacturer's objective is to maximize his profit. Second, the time-scales of the incentives differ: Drèze and Bell (2003) consider short-term incentives (applying only during a promotion period) and Taylor (2002) , Krishnan et al. (2004) and Aydin and Porteus (2009) consider incentives for a short life-cycle product (one-period selling season); in contrast, we consider long-term incentives for a long life-cycle product. Our finding that, for a short life-cycle product, the donor may benefit from rewarding the retailer based on her sales, similar to the finding in the contracting literature, indicates that the time-scale of the incentive is important in driving the results.
Operations management researchers have examined subsidies for short life-cycle products. Research on the influenza vaccine supply chain (e.g., Chick et al. 2008 , Arifoglu et al. 2012 ) identifies social-welfare enhancing interventions and subsidies that influence manufacturer production decisions in settings where the production yield is uncertain and consumers' purchasing decisions are influenced by the fraction of the population that is vaccinated. In a setting with a price-setting newsvendor retailer, Ovchinnikov and Raz (2013) show that a purchase subsidy (or sales subsidy) can be designed either to induce the retailer to choose the social-welfare maximizing price or to choose the social-welfare maximizing quantity, but not both. Numerically, they observe that a sales subsidy is more effective than a purchase subsidy in terms of social-welfare maximization. Instead of comparing the two subsidies, we characterize the optimal mix of subsidies analytically.
Model Formulation and Preliminaries
We consider a donor (he) that offers subsidies to a retailer (she) that sells to end consumers. The donor seeks to maximize sales to consumers subject to a budget constraint, whereas the retailer seeks to maximize her expected profit. Although, for simplicity, we model consumer sales as taking place through a single retailer, our results extend to the case with multiple, heterogenous retailers, as described in §4.
The retailer sells to end consumers over a time horizon with an infinite number of time periods, indexed by  = 1 2 . In period , consumer demand depends on the market condition   , where  1   2   are independent and identically distributed random variables with distribution  , density  and continuous support on [0 ∞).
The sequence of events is as follows: First, the donor offers a per-unit purchase subsidy  ≥ 0 and a per-unit sales subsidy  ≥ 0 The retailer begins with zero inventory. In each period , the retailer places and receives an order, incurring per-unit acquisition cost   0 less the per-unit purchase subsidy . The market condition uncertainty is resolved, and the retailer observes the market condition   =  The retailer sets the price  ≥ 0 and demand ( ) is realized. For each unit the retailer sells, the retailer receives the price  from the end consumer, and the donor pays the retailer the sales subsidy . Finally, the leftover inventory is carried over to the next period, incurring a per unit holding cost which is normalized to zero without loss of generality. Our assumption that leftover inventory is carried over to the next period is motivated by the relatively long shelf-life of ACTs, 24 to 36 months (Anthony et al. 2012) . Our assumption that, between replenishment intervals, the retailer has freedom to set her price in response to market conditions reflects the fact that retailers-especially in rural regions-in developing countries have substantial discretion in adjusting their prices. Typically, they do not advertise or otherwise post prices in advance, and they face relatively little in the way of regulatory scrutiny.
Consumer demand ( ) = () In the special case where () ≤ 1 for  ≥ 0 the market condition  can be interpreted as the number of customers in need of the product (e.g., due to infection), and () can be interpreted as the fraction of potential customers that purchase the product under price . We impose the following two mild assumptions on ():
(A1) () is continuous, twice differentiable, and strictly decreases in  on  ≥ 0 with () = 0
Assumptions (A1) and (A2) are satisfied by common demand functions studied in the literature, Song et al. 2009 ).
We next formulate the retailer's ordering and pricing problem under any given subsidy ( ), and then turn to the donor's problem. Consider any given period. Let  denote the retailer's inventory before ordering. The retailer makes ordering and pricing decisions to maximize her expected discounted profit, under discount rate  ∈ (0 1). Specifically, the retailer chooses order quantity  −  ≥ 0 so as to bring her inventory up to  ≥  and incurs purchase cost ( − )( − ). After observing the realized market condition , the retailer chooses price , which results in sales of min(() ) and revenue ( + ) min(() ). The leftover inventory  − min(() ) is carried into the next period. Consequently, the retailer's expected discounted profit is
By adapting well-known arguments for the case with an exogenous price (e.g., Karlin 1958) , one can show that a myopic ordering and pricing policy is optimal. All proofs are in the appendix. Lemma 1. In each period, the retailer's optimal decisions are to order so as to bring her inventory up to  * , and after observing the market condition  to set the price equal to  * (  * ) where  * and  * (  * ) are the order quantity and price that maximize the retailer's expected profit in a single period where each unsold unit has salvage value ( − ). That is,  * and  * (  * ) are the solution to
Intuitively, the retailer's optimal policy is stationary because the underlying parameters are stationary. In each period, the retailer orders up to  *  so by carrying a unit of unsold inventory into a subsequent period, the retailer avoids the cost of purchasing that unit,  −  in the subsequent period. From the perspective of the retailer's ordering decision, these cost savings are discounted by  because they occur in the subsequent period.
Now we turn to the donor's problem, which is to maximize the retailer's sales subject to a budget constraint on the donor's subsidy payment, in a sense that will be made precise momentarily. It follows from the above characterization of the retailer's problem that the quantity sold in each period is min(( * (  * ))  * ), a random variable that is stationary over the time horizon. Consequently, maximizing expected discounted sales over the time horizon is equivalent to maximizing expected per-period sales, which is equivalent to maximizing average sales per pe-
For concreteness, we assume the donor maximizes average sales per period, but our formulation admits either of the other two objectives. We now turn to the budget constraint. In each period  ≥ 2, the retailer's order quantity is equal to
  have identical distributions, the retailer's purchase quantity and sales quantity have identical distributions. Consequently, from period 2 onwards, in each period, the donor's expected pur-
and his expected sales subsidy payment is
. This implies that the donor's average subsidy payment per period over the infinite time horizon is
The donor's problem is to choose the purchase subsidy  and the sales subsidy  to maximize the average per-period sales to consumers, subject to the constraint that the average per-period subsidy payment does not exceed the budget : 1
Because the donor is trying to influence two decisions of the retailer-her stocking decision and her pricing decision-and because the two different subsidy types influence these decisions in different ways, it might be natural to conjecture that the donor's optimal subsidy would consist of both subsidy types, i.e.,  *  0 and  *  0 at least for some parameters. In the next section, we show this conjecture is false: the optimal subsidy consists solely of a purchase subsidy, i.e.,  * = 0
1 Our results extend to the case where the budget constraint is based on the donor's expected discounted subsidy payment, provided that the donor's discount factor is sufficiently large. The latter is realistic in the malaria drugs context because the interval between periods is relatively short (the retailer's replenishment interval is typically on the order of weeks) and because donors invest committed funds conservatively prior to disbursement (consequently, donors' value from postponing payments is relatively small).
Results
We begin by characterizing the retailer's optimal pricing and ordering decisions under subsidy ( ).
From Lemma 1, the retailer's optimal price is the price that maximizes retailer expected profit in a single period where unsold units have salvage value ( − ) i.e., the maximand in (1). This holds for any order-up-to level  that the retailer employs, because by carrying a unit of unsold inventory into a subsequent period, the retailer avoids the cost of purchasing that unit in that period. To understand how the donor's subsidies impact the retailer's decisions it is useful to write the retailer's one-period expected profit under inventory level  as
The first term is the net cost of purchasing  units and then salvaging them at the end of period;
this is the loss the retailer would incur if she sold zero units. The second term is the revenue from selling units, less the forgone salvage value. For each unit the retailer sells, she receives the price  and the sales subsidy  but she gives up the value of carrying the unit into the next period
The retailer's price is only influenced by the acquisition cost  and acquisition subsidy  in that they impact the value of unsold units. Consequently, for any subsidy ( ), order-up-to level  and realized market condition  the retailer's optimal price is
In (3), we generalize the notation for the retailer's optimal price to reflect the dependence of the optimal price on the subsidy
Lemma 2. Under subsidy ( ), order-up-to level , and realized market condition , the retailer's optimal price is
Intuitively, the retailer prices to sell her entire stock (i.e., she sells  units) when market condition is strong
but prices to withhold stock (i.e., she sells (( + )) which is strictly less than her stock )
when the market condition is weak
Consequently, stocking a larger quantity (using a larger order-up-to level ) leads the retailer to price more aggressively, strictly so if and only if the market condition is strong (4). Both subsidies encourage the retailer to price more aggressively, but the sales subsidy is more effective in doing so. More precisely, for any given order-up-to level  and realized market condition  the retailer's optimal price  * (   ) decreases more rapidly in the sales subsidy  than in the purchase subsidy
where the inequalities are strict if and only if the market condition is weak (5). We refer to this as the pricing effect. (When the market condition is strong (4), the retailer prices to sell out regardless of the subsidies. Consequently, marginal changes in either subsidy do not impact the retailer's pricing decision.)
The two subsidies encourage the retailer to price more aggressively, but for different reasons.
The sales subsidy encourages the retailer to price more aggressively because the retailer receives not only the price but also the sales subsidy for each unit she sells, which makes it attractive for the retailer to reduce her price so as to increase the volume of units that are eligible for the subsidy. The reason why the purchase subsidy encourages more aggressive pricing is more subtle.
The purchase subsidy, by reducing the cost of acquiring units in the subsequent period, reduces the value to the retailer of carrying unsold units into the next period. Consequently, the retailer prices more aggressively to clear out her existing inventory. Because the sales subsidy impacts the retailer's profit immediately whereas the purchase subsidy impacts the retailer's profit in the next period, the donor must offer a more generous purchase subsidy in order to have the same impact on the retailer's price. Specifically, to have the same impact on the retailer's pricing decision as sales subsidy  requires purchase subsidy  =  Although sales subsidy  and purchase subsidy  =  have the same impact on the retailer's pricing decision under a fixed order-up-to level, we will see below that the two subsidies have different impacts on the retailer's optimal order-up-to level.
We now turn to the retailer's optimal ordering decision. As noted above, the retailer's optimal order-up-to level is the order quantity that maximizes retailer expected profit in a single period where each unsold unit has salvage value ( − ) Embedding the optimal price from Lemma 2, we can write the retailer's one-period expected profit under subsidy ( ) and inventory level  more explicitly as
The next lemma characterizes the retailer's optimal order-up-to level  * ( ).
Lemma 3. The retailer's one-period expected profit (  ) is strictly concave in the order-up-to level . Its unique maximizer  * ( ) is the unique solution to
where ( ) ≡ { −1 ()}.
The retailer's one-period expected profit under inventory level  consists of two elements: the cost of stocking and not selling units (i.e., the net cost of purchasing and then salvaging  units), and the contribution (i.e., revenue less purchase cost) from selling units. The retailer chooses an order-up-to level that equates the marginal contribution from stocking and selling a unit (the left hand side of (7)) with the marginal cost of stocking and not selling a unit (the right hand side of (7)).
Expression (7) illuminates the distinct mechanisms by which each subsidy increases the retailer's optimal order-up-to level  * ( ) An incremental dollar of sales subsidy has the same impact as an incremental dollar of purchase subsidy on the marginal contribution from stocking and selling a unit. However, only the purchase subsidy impacts the marginal cost of stocking and not selling a unit. Therefore, the purchase subsidy is more effective in boosting the retailer's order-up-to level.
Formally, the retailer's optimal order-up-to level  * ( ) increases more rapidly in the purchase subsidy  than in the sales subsidy 
We refer to this as the quantity effect.
From Lemmas 2 and 3, the average per-period sales to consumers is
where the retailer's optimal order-up-to level  * ( ) satisfies (7).
The donor's problem is to choose the purchase subsidy  and the sales subsidy  to maximize the average per-period sales to consumers, subject to the constraint that the average per-period subsidy payment does not exceed the budget  :
Increasing each subsidy causes the retailer to increase her stock level and to price more aggressively, both of which further the donor's objective of increasing sales to consumers. However, increasing each subsidy also increases the donor's subsidy payment. How should the donor optimally choose the mix of purchase subsidy  and sales subsidy ?
To build intuition about the donor's optimal mix of subsidies, it is useful to examine how each subsidy impacts the volume of sales to consumers. Both subsidies increase the retailer's sales volume S( ) not only by encouraging the retailer to stock more ex ante (the quantity effect), but also by inducing the retailer to price more aggressively ex post (the pricing effect). However, the magnitude of these two effects differs under the two subsidies. As noted in (6), the sales subsidy is stronger in encouraging the retailer to price more aggressively (for any given order-up-to level ). In contrast, as noted in (8), the purchase subsidy is stronger in encouraging the retailer to stock more aggressively.
Let (4 0 ) and (5 0 ) denote (4) and (5), where  =  * ( ) When the market condition is strong (4 0 ), the pricing effect is irrelevant because the retailer prices to sell her entire stock; consequently, only the quantity effect impacts sales to consumers. In contrast, when the market condition is weak (5 0 ), the quantity effect is irrelevant because the retailer prices to withhold stock; consequently, only the pricing effect impacts sales to consumers.
To summarize, the sales subsidy is more effective in increasing sales when the market condition is small, but the purchase subsidy is more effective in increasing sales when the market condition is strong. Lemma 4 establishes that, averaging across market condition realizations, the latter effect dominates the former: the purchase subsidy is more effective in increasing average per-period sales to consumers. This is plausible in that when the market condition is small (which can be interpreted as there being few customers in the market), the amount by which the subsidies impact the magnitude of sales to consumers is limited. Because the pricing effect (which favors the sales subsidy) is only at work when the market condition is small, the magnitude of the this effect is limited-in a way that the magnitude of the quantity effect (which favors the purchase subsidy) is not. The observation that, regardless of the subsidy levels ( ), a marginal increase in the purchase subsidy is more effective than a marginal increase in the sales subsidy in increasing sales to consumers (Lemma 4) is the key insight which drives the donor's optimal mix of subsidies (Proposition 1). To see this, consider any subsidy ( ) where the sales subsidy   0. From Lemma 4, the same average per-period sales to consumers can be achieved by eliminating the sales subsidy and increasing the purchase subsidy  by an amount that is strictly smaller than . Clearly, this modification strictly reduces the average per-period subsidy payment. Consequently, any subsidy ( ) with   0 cannot be optimal. This establishes the paper's main result.
Proposition 1. The donor's optimal subsidy consists solely of a purchase subsidy, i.e., the optimal sales subsidy  * = 0.
Proposition 1 is consistent with industry practice in that current subsidy for ACTs, as provided through the Affordable Medicines Facility-malaria, is solely a purchase subsidy-a subsidy that reduces the distribution channel's acquisition cost (Adeyi and Atun 2010) .
Robustness
In this section we consider the extent to which our main finding-the donor should offer a purchase subsidy but not a sales subsidy-is robust to two of our key assumptions: the donor designs his subsidy with a single retailer in mind, and the product has a long life cycle such that leftover inventory can be sold in a subsequent period.
Heterogenous Retailers
The formulation with a single retailer informs the donor's decision when a particular type of retailer (e.g., a drug shop) is the primary means by which consumers access the product in the region where the subsidy is offered, and retailers of this type are relatively homogenous. Then, the donor can design his subsidy with this representative retailer in mind. The formulation is also appropriate when the donor is able to tailor his subsidy to each retailer (or to each type of retailer, in the case that retailers fall into categories). Proposition 1 implies that when the donor facing  retailers is able to offer a different subsidy (     ) to each retailer  ∈ {1  }, it is optimal to set each retailer 's sales subsidy  *  = 0 and to only offer purchase subsidies. However, offering different subsidies to different retailers entails administrative costs and introduces the threat of product diversion. Consequently, a donor may be compelled to offer a uniform subsidy ( ) to a heterogenous pool of retailers. This section shows that the result from the tailoredsubsidy case carries over to the uniform-subsidy case: the optimal uniform subsidy ( *   * ) has sales subsidy  * = 0 Specifically, consider  retailers, each facing a common subsidy ( ). Retailer 's per-unit acquisition cost is   . The market condition for retailer  ∈ {1  } in period  ∈ {1 2 },     has distribution   and density    Under market condition    =   and price
Retailer 's optimal order-up-to level and price under any subsidy ( ) are given in Lemmas 2 and 3. The donor's problem is to choose the purchase subsidy  and the sales subsidy  to maximize the average per-period sales to consumers across all retailers, subject to the constraint that the average per-period subsidy payment across all retailers does not exceed the budget 
where S  ( ) is retailer 's average per-period sales to consumers. Our main result, Proposition 1, extends when the donor faces multiple retailers.
Proposition 2. Suppose the donor faces heterogenous retailers. The donor's optimal subsidy consists solely of a purchase subsidy, i.e., the optimal sales subsidy  * = 0.
Short Life-cycle Product
We have assumed that the product has a sufficiently long life cycle that leftover inventory can be sold in a subsequent period. The mostly commonly used ACTs have a shelf life of 24 months from the time of manufacturer, although some have a shelf life of 36 months (Anthony et al. 2012) . If the time from manufacturer to the time of retailer receipt of the product is not too long (measured in months rather than years) and the retailer's replenishment interval is not too long (weekly or monthly rather than annually), then this assumption is a reasonable approximation. However, for some retailers that are remotely located, where transportation is difficult and costly, these assumptions may not be realistic and the perishability of the product may be a real concern. In effect, by the time the retailer receives the product, its remaining life cycle is short. As an approximation of this case, in this section we consider the case where the product's remaining shelf life is short relative to the retailer's replenishment interval, such that inventory left over after a selling period perishes. As in the base model, we consider the subsidy over repeated periods; the donor's problem is to maximize average per-period sales subject to the average per-period subsidy payment not exceeding a budget.
When inventory perishes at the end of a selling period, the retailer's one-period expected profit under subsidy ( ) and inventory level  is
which is mathematically identical to the value in the base model analyzed in §3, where the discount factor  = 0 Intuitively, when inventory perishes prior to the subsequent selling season, this decouples the periods from one another such that the retailer faces a sequence of stochastically identical, uncoupled problems. Consequently, the retailer's optimal price  * (   ) and order quantity  * ( ) are as stated in Lemmas 2 and 3, where  = 0 Consequently, the average per-period sales to consumers S( ) is given by (9), where  = 0 Further, inequalities (6) and (8), as well as Lemma 4, continue to hold.
The donor's problem is to choose the purchase subsidy  and sales subsidy  to maximize the average per-period sales to consumers, subject to the constraint that the average per-period subsidy payment does not exceed the budget . In each period, the donor pays the purchase subsidy  on each unit the retailer purchases  * ( ) and the sales subsidy  on each unit the retailer sells S( ).
Therefore, the donor's average per-period subsidy payment is
which is equivalent to the donor's expected subsidy payment in a single period. Therefore, the donor's problem is
Recall that when the product has a long life cycle, the donor's optimal subsidy consists solely of a purchase subsidy, i.e., the optimal sales subsidy  * = 0 (Proposition 1). To what extent does this result continue to hold when the product has a short life cycle?
The donor's optimal mix of subsidies is driven by three effects, the first two of which carry over from the long life-cycle product setting. First, the pricing effect (6) favors the sales subsidy: for any inventory level  the sales subsidy is more effective in encouraging the retailer to price aggressively.
Second, the quantity effect (8) favors the purchase subsidy: the purchase subsidy is more effective in encouraging the retailer to stock aggressively. However, a key feature of the setting where the product has a long life cycle-that the purchase subsidy has the effect of reducing the value of unsold inventory (because units that are carried over into the next period can be acquired more cheaply)-disappears when the product has a short life cycle. A consequence is that the product's having a short life cycle makes both the pricing effect and the quantity effect more pronounced: the product's having a short life cycle makes the sales subsidy even more effective relative to the purchase subsidy in encouraging the retailer to price aggressively, but even less effective in encouraging the retailer to stock aggressively.
The product having a short life cycle introduces a third effect, which we label the payment effect.
When the product has a short life cycle, the sales subsidy is more attractive to the donor in that the donor only pays the sales subsidy on units the retailer sells, which is fewer than the units the retailer purchases. (In contrast, when the product has a long life cycle, in each period, the quantity to which the sales subsidy is applied and the quantity to which the purchase subsidy is applied have identical distributions; see §2.)
Because Lemma 4 extends to the case where the product has a short life cycle, we know that, in terms of increasing average per-period sales, the purchase subsidy is more effective than the sales subsidy (i.e., the quantity effect dominates the pricing effect). Therefore, we are left with two countervailing forces. The purchase subsidy is more effective than the sales subsidy in increasing the donor's objective. However, the purchase subsidy is also more costly to the donor (the payment effect). How do these effects interact to determine the optimal mix of donor subsidies?
Intuition suggests that the donor's optimal subsidy will include a sales subsidy  *  0 only when one or both of the factors that favor the sales subsidy are strong: the payment effect and the pricing effect. We now argue that the payment effect tends to be stronger when budget is large. When the budget (and hence subsidy level) is small, the retailer will tend only to purchase units she is quite confident she will sell. Because the quantity to which the sales subsidy applies (sold units) differs little from the quantity to which the purchase subsidy applies (purchased units), the payment effect is small. When the budget (and hence subsidy level) is large, the retailer will tend to be willing to stock aggressively, recognizing that for some realizations of the market condition she will be left with unsold inventory. That is, the gap between the (average) quantity to which the sales subsidy applies and the quantity to which the purchase subsidy applies is significant; consequently, the payment effect will tend to be large. In sum, the payment effect becomes increasingly important as the budget increases.
Intuition suggests that the pricing effect becomes more important as the customers become more heterogenous in their willingness to pay. If customers are completely homogenous in their willingness to pay (i.e., they share a common valuation), then the pricing effect is irrelevant because the retailer will set her price equal to the common valuation regardless of the subsidy. As customers become more heterogenous in their willingness to pay, the retailer's pricing decision becomes more important and is more influenced by the subsidies.
All this suggests that the donor's optimal subsidy will include a sales subsidy  *  0 when the budget is large and customers are sufficiently heterogenous in their willingness to pay, but will not include a sales subsidy  * = 0 when these factors are not present. We now turn to formally establishing this conjecture. For convenience, we adopt a specific functional form for the demand curve where customer heterogeneity is captured in a single parameter
The case with linear demand (10) corresponds to the case where customers in need of the product are uniformly distributed in their willingness to pay over the interval
is a measure of the degree of heterogeneity in the customers' willingness to pay. (Although (10) deviates from assumption (A1) when ∆   the four lemmas leading up to Proposition 1 continue to hold. The only exception is that results parallel to Lemmas 2 and 3-see Lemmas 2A and 3A in the appendix-characterize the retailer's optimal decisions.)
Proposition 3. Suppose the product has a short life cycle and that demand is linear (10). There exists  ∈ (0 ∞) such that if the donor's budget    or customer heterogeneity ∆ ≤ 3 then the donor's optimal subsidy consists solely of a purchase subsidy, i.e., the optimal sales subsidy  * = 0. Otherwise, the donor's optimal subsidy consists of both subsidies, i.e., the optimal purchase subsidy  *  0 and the optimal sales subsidy  *  0
Lemma 5 in the appendix characterizes how the optimal subsidies ( *   * ) change as the budget  increases. For the interesting case where customer heterogeneity ∆  3  * and  * weakly increase in the budget. As the budget increases from zero, initially only the purchase subsidy  * strictly increases, then only the sales subsidy  * strictly increases, and then finally, only the purchase subsidy  * increases.
We conclude that a donor subsidizing a short life-cycle product should only offer a sales subsidy when his budget and customers heterogeneity in willingness to pay are sufficiently large. The health condition of a patient prior to contracting malaria impacts the health consequences of contracting the disease (e.g., a person with HIV tends to suffer more severe health consequences from malaria), which impacts the value the patient attaches to effective treatment. Consequently, heterogeneity in willingness to pay will tend to be most pronounced when the customer population exhibits significant heterogeneity in health conditions and income.
Conclusion
This paper provides guidance to donors designing purchase and sales subsidies to improve consumer access to a product in the private-sector distribution channel. Specifically, we describe how the product's characteristics (short vs. long life cycle), customer population (degree of heterogeneity) and the size of the donor's budget impact the donor's subsidy design decision. It is always optimal to offer a purchase subsidy. It is optimal to offer a sales subsidy (in addition to a purchase subsidy) if and only if the product has a short life cycle and the customer heterogeneity and the donor's budget are sufficiently large. These results suggest that for long life-cycle ACTs, donors should only offer purchase subsidies.
Although we have focused on ACTs, our results could inform donor subsidy decisions for other products. As with ACTs, for other medicines, in much of the developing world the private sector is the primary way patients access treatment (Prata et al. 2005 , International Finance Corporation 2007 ), yet private-sector supply chains fail in providing high levels of availability of medicines (Cameron et al. 2009 ). For example, oral rehydration salts (ORS) are the first-line treatment for childhood acute diarrhea, the second-leading cause of child mortality worldwide. Most treatment for childhood acute diarrhea is accessed in the private sector, but only 30% of children with diarrhea in high burden countries receive ORS. The United Nations' newly launched Commission on Commodities for Women's and Children's Health is examining ways to increase access to essential medicines such as ORS (Sabot et al. 2012) . One option, which has received limited testing, is to subsidize ORS (MacDonald et al. 2010 , Gilbert et al. 2012 ).
We conclude by mentioning two aspects of our model formulation. First, we have not modeled the administrative costs to implement each type of subsidy. Because these costs will tend to be higher for the sales subsidy, including such costs would tend to reinforce our conclusion that for long life-cycle products, donors should only offer purchase subsidies. Second, because donors are primarily interested in the availability and affordability of ACTs at the point where products are made available to consumers (Laxminarayan and Gelband 2009) , it is essential that a model include the retailer's stocking and pricing decisions. To allow for generality in some dimensions of the model (demand function, market uncertainty, heterogenous retailers, long-and short-life-cycle products), we have abstracted away from the stocking and pricing decisions of the manufacturers and wholesalers in the distribution channel. On the pricing side, retailers' markups are larger than those at wholesale levels (Patouillard et al. 2010) , which suggests that retailers' pricing decisions may be more important.
Nonetheless, it would be valuable to understand how subsidies impact the decisions of all firms in the distribution channel. It is straightforward to verify that () is strictly unimodal and has a unique maximizer. It follows from (11) that  0 () ≤  0 (), where the inequality holds with equality if  ≤  *  Because  * is a maximizer of (),  0 ( * ) = 0. Therefore,  0 ( * ) = 0, which together with the fact that () is strictly unimodal, implies that  * is also the maximizer of (). Hence  0 ()  0 for    * , which together with the result that  0 () ≤  0 (), implies that  0 ()  0 for    * . Consequently, the retailer's optimal ordering policy is: if the starting inventory  is less than  * , order  * −  to bring the inventory up to  * ; otherwise, ordering nothing.
Because the retailer's starting inventory in period 1 is zero, under the above optimal ordering policy, the starting inventory in any period will not exceed  * and thus the inventory after ordering in any period is  * . This implies that the retailer's optimal pricing decision depends only on the realized market condition :
which together with the earlier result that  0 () =  −  for  ≤  * , implies that Thus, we can rewrite  * (   ) as follows:
The objective function [ +  − ( − )]() is unimodal with a unique maximizer because its first-order derivative with respect to  is
which changes sign at most once, by (A1) and (A2). Because () strictly decreases in , constraint (12) can be rewritten as  ≥  −1 (). This, together with the result that the objective function is unimodal, implies that  * (   ) =(+) (i.e., the maximizer of the unconstrained problem) if
Proof of Lemma 3: Note that
Note that in deriving the above equality, we have used the following result
where the last equality follows from the first-order condition that must be satisfied by the maximizer
By definition of ( ), we have
where  =  −1 (). In (13), the term in square brackets is strictly positive because for
where the inequality follows from (A2) and the equality follows from (A1). In (13), the first term is negative because, by (A1),  0 ()  0. This implies ( )  0, which, in turn, implies that  2 (  ) 2  0. Therefore, (  ) is strictly concave in  and its unique maximizer  * ( ) is determined by the first-order condition (7).¥ Proof of Lemma 4: Because  * ( ) is the unique solution to (7), we have
By (9),
where the last equality follows from (14) and (15).
By (13) and the assumption (A2) that
Recall that( + ) = arg max ≥0 ( +  +  − )(). It follows from the first-order condition
Taking the derivative of both sides of the above equation with respect to , we have
or equivalently,
which together the first-order condition  +  +( + )
This, together with (17), implies that where the sales subsidy   0. It follows from Lemma 4 that
implying that the same average per-period aggregated sales over the  retailers can be achieved by eliminating the sales subsidy and increasing the purchase subsidy  by an amount that is strictly smaller than . Clearly, this modification strictly reduces the average per-period subsidy payment. Consequently, any subsidy ( ) with   0 cannot be optimal. ¥ The remainder of the appendix addresses the case in which the product has a short life cycle and demand is linear (10). Arguments parallel to those in the proofs of Lemmas 2 and 3 establish the retailer's optimal pricing and ordering decisions, which we state in Lemmas 2A and 3A, respectively. Lemma 2A. Suppose the product has a short life cycle and that demand is linear (10). Under subsidy ( ), order-up-to level , and realized market condition , the retailer's optimal price is
Suppose the product has a short life cycle and that demand is linear (10). The retailer's one-period expected profit is strictly concave in the order quantity . Its unique maximizer  * ( )
is the unique solution to
Let  and  be the donor's average per-period subsidy payment under the subsidy ( ) = (2 0) and the subsidy ( ) = (2 max(3∆ −  0)), respectively. Clearly,  ≥ . Proof of Lemma 5: From Lemma 2A, the average per-period sales to consumers
This expression, as well as the expression for the retailer's optimal order quantity  * ( ) simplifies based on whether  +  ≤ 3∆ or  +  ≥ 3∆ Therefore, we can rewrite the donor's problem (P) for these two cases: 
The subsidy ( 0   0 ) also satisfies the third constraint because  ≥ 3∆ and  0 = 0 Therefore, ( 0   0 ) is a feasible solution to (P2). Because the objective value of (P2) is the same under ( 0   0 ) and ( *   * ) ( 0   0 ) must also be an optimal solution to (P2). However, from (18), the average per-period subsidy payment under ( 0   0 ) is strictly less than the budget  Therefore, one can increase  0 by a small amount, and by doing so strictly increases the retailer's order quantity and the objective value of (P2) without violating any constraint of (P2). This contradicts that ( 0   0 ) is an optimal solution to (P2). We conclude that the optimal sales subsidy  * = 0
Second, suppose 3∆   This implies that the third constraint must be binding at any optimal solution to (P2). If not, then one can construct a strictly better solution to (P2) by following the same arguments as above. Therefore, (P1) dominates (P2), and it suffices to solve (P1). Note that the first constraint of (P1) must be binding at the optimal solution, because otherwise the donor can strictly increase the average sales per-period by increasing the purchase subsidy by a sufficiently small amount without violating any constraint of (P1). We can then use the first two constraints to eliminate the decision variable , and rewrite (P1) as follows: We next derive the optimal solution to the relaxed version of (P1 0 ) wherein the third constraint is dropped. It is straightforward to verify that the optimal solution to the relaxed problem satisfies the third constraint and thus is also optimal for (P1 0 ). 
Note that  (

